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ABSTRACT
Objective: the aim of this study is to assess the importance of
NOD2/CARD15 gene mutations as prognostic factors for surgi-
cal indications in Crohn’s disease.
Patients and experimental design: a total of 165 Crohn’s
disease patients were studied, considering previous surgery related to
Crohn´s disease. We analyzed for previous surgery in global proce-
dures as well as separately for the two main surgical indications: ileal
resection and fistula treatment. The need for appendectomy was also
studied. All patients were genotyped for the three CARD15 muta-
tions, and association studies were developed using Chi-square statis-
tics and Fisher’s exact test whenever appropriate.
Results: carriers of the G908R or 1007fs mutation needed
surgery more frequently, both for ileal resection and fistula repair.
In contrast, appendectomy was not associated with CARD15 mu-
tations.
Conclusions: as previously reported in this population, the
R702W mutation does influence parameters of disease or need of
surgery. The need for Crohn’s disease-related surgery is higher in
carriers of the G908R or 1007fs CARD15 mutation in the Gali-
cian population. Nevertheless, the frequency of these mutations
does not allow their use to predict the course of disease. 
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INTRODUCTION
The etiology of Crohn’s disease (CD) is still unknown.
However, there is consensus that an inappropriate mucos-
al immune response to normal constituents of the intesti-
nal microflora in genetically susceptible individuals is
important in the pathogenesis. Although several genes
have been involved in the susceptibility of this disease
(1,2), the CARD15 gene, previously called the NOD2
gene, is the main susceptibility gene to CD in most stud-
ied populations (1,3). The CARD15 gene is located in the
pericentromeric region of chromosome 16 (16q12) and
codes for a NOD2 protein, which acts as an intracellular
receptor for bacterial components, specifically peptido-
glycans. There are three functional mutations of the
CARD15 gene, two missense variants and one deletion:
R702W, G908R and 1007fs, respectively. However, these
mutations are not present in all the populations studied so
far. Important differences in the frequency of these muta-
tions have been observed according to each population’s
race and geographic location (4-13). In most of the stud-
ies reported, the presence of CARD15 mutations has
been associated with ileal disease, which usually implies
a need for surgery with higher frequency.
Recently, we reported a study carried out in the Gali-
cian population (13). CD was significantly associated
with G908R and 1007fs mutations, although with a
smaller frequency versus the majority of Caucasian pop-
ulations. CD patients require surgery at some point dur-
ing their lives, with ileal resection and fistula repair being
the most frequent procedures. It is noteworthy that a high
number of these patients also needed appendectomy, pre-
viously to or at the time of diagnosis. However, the rela-
tionship of these three main mutations of the CARD15
gene with CD-related surgery has not been specifically
studied as far as we know.
The aim of our work was to assess the influence of
CARD15 mutations on the various CD-related surgical
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procedures, and to determine whether these mutations
may be used to predict need of surgery.
METHODS
Patients and controls
A total of 165 patients with Crohn´s disease followed up
in the Inflammatory Bowel Disease Unit, Gastroenterolo-
gy Department, at Hospital Clínico Universitario, Santiago
de Compostela were studied. All patients were Galician
and residents of Galicia. As controls, a group of 165
healthy, unrelated, ethnically-matched individuals with no
family history of IBD and with similar characteristics re-
garding age, sex and origin were chosen (controls were
also Galician and residents of Galicia). From each subject
a blood sample in EDTA tubes was obtained by venipunc-
ture with the corresponding written informed consent. The
hospital ethical committee approved the protocol.
The diagnosis of CD was made by clinical, radiologi-
cal, endoscopic, and histological investigations. The pa-
tients and their data were reviewed by the same gastroen-
terologist to confirm the diagnosis and to avoid different
criteria for diagnosis establishment. A retrospective study
of patients regarding previous need for CD-related
surgery was performed in collaboration with the Surgery
Department of the same Hospital. The analysis was also
stratified according to the two most frequent procedures
in these patients, namely ileal resection and fistula (main-
ly perianal) repair. The history of appendectomy before
the development of the disease or at the time of diagnosis
was also analyzed.
Determination of CARD15 mutations
As previously published, genomic DNA was isolated
from blood samples obtained from each individual using
a Roche DNA isolation kit (Roche Molecular Biochemi-
cals, Mannheim, Germany). All study participants were
genotyped for the three mutations described as involved
in CD (R702W, G908R and 1007fs) by means of PCR-
RFLP. Restriction fragments were isolated on 2%
(G908R) or 4% (R702W and 1007fs) agarose gels and vi-
sualized with ethidium bromide. Primers used to assay
the R702W polymorphism included:
5’CGCACAACCTTCAGATCACA3’ (forward) and
5’GGATGGAGTGGAAGTGCTTG3’ (reverse).
For the G908R variant:
5’AAGTCTGTAATGTAAAGCCAC3’ (forward) and 
5’CCCAGCTCCTCCCTCTTC3’ (reverse), 
And the primers used for the 1007fs polymorphism in-
cluded:
5’GGCAGAAGCCCTCCTGCAGGGCC3’ (forward)
and
5’CCTCAAAATTCTGCCATTCC3’ (reverse).
The association of the various mutations with CD, over-
all or each specific subphenotype, was studied employing
Chi-square tests or Fisher´s exact test when necessary.
Analyses were performed considering the influence of
each specific mutation on CD as well as the influence of
carrying more than one mutation. P values < 0.05 were
considered significant. Statistical analyses were performed
using the SPSS software v. 11.0. This study has been ap-
proved by the Ethical Committee for Clinical Investigation
of Galicia (2002/151).
RESULTS
All 165 consecutive patients included in this study
were followed up for a mean of 8 years since the diagno-
sis of disease, with a range of 1-33 years. Mean age was
36 years, with a range between 17 and 76. A slight pre-
dominance in women was seen (57.6%).
A total of 85 patients (51.5%) underwent a surgical
procedure related to CD. Among them, 51 patients (60%)
had needed an ileal resection, sometimes more than once,
and 19 patients (22.4%) had been treated for fistulae; 32
patients (19.4%) had been appendectomized before or at
the time of CD diagnosis.
In all, 27.9% of patients carried at least one of the
CARD15 mutations previously associated with CD. An
R702W mutation was observed in 22 patients (13.3%),
G908R in 13 (7.9%) and 1007fs was observed in 14 pa-
tients (8.5%). The R702W mutation showed also a relative-
ly high frequency (11.5%) in the Galician subjects without
CD used as controls, similar to a previously reported study
in another population (13). Therefore, this mutation does
not seem to be involved in CD susceptibility.
The overall analysis of results showed that 39.1% of
patients operated for CD (fistulae or ileal resection)
showed at least one of the three main mutations in
CARD15 vs. 19.8% of surgery-naïve CD patients. Differ-
ences between both groups were statistically significant
(p < 0.01). Considering only individuals carrying the two
mutations previously associated with CD in the Galician
population, G908R and 1007fs, 27.5% of them had un-
dergone surgery, which is in contrast to only 6.3% who
had not been operated (p < 0.001). A more detailed
analysis of the surgical procedures performed showed
that CARD15 mutations were significantly more frequent
in patients having undergone ileal resection (43.1%) than
in those without ileal resection (21.1%) (p = 0.003). Sta-
tistically significant differences were also observed when
individuals carrying only G908R and 1007fs were con-
sidered, 29.4 vs. 8.8% of carriers who had or had not un-
dergone surgery (p = 0.001). Patients treated for fistulae
had a higher frequency of CARD15 mutations, but differ-
ences were only significant when patients carrying both
mutations were considered; 29.4% of the patients operat-
ed on for fistulae carried G908R and 1007fs vs. 8.8% of
patients not operated on (p < 0.01).
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The individual analysis of each mutation showed that
the R702W mutation has approximately the same fre-
quency in patients operated or otherwise (13.0 vs. 13.5%,
respectively). The G908R mutation showed a statistically
significant higher frequency in previously operated pa-
tients (14.5%) versus non-operated patients (3.1%). The
insertion mutation (1007fs) was observed in 14.5% of op-
erated patients and in 4.2% of non-operated patients (p <
0.05). The frequency of each mutation regarding the dif-
ferent kind of surgery considered in this study is shown
in table I. When the results of each surgical indication
were analyzed individually, we found that carriers of the
G908R mutation showed a significantly higher frequency
of fistula treatments (31.6 vs. 4.8%; p < 0.01). Regarding
ileal resections, the 1007fs variant was found to be signif-
icantly associated with this kind of surgery (17.6% of
ileal resection patients carried this mutation vs. 4.4% of
patients not having undergone this operation p < 0.05).
The G908R variant was also more frequent in patients
with fistula repair (13.7 vs. 5.3%), but differences were
not significant (p < 0.1).
An association was found between CARD15 muta-
tions and appendectomy. However, the frequency of
CARD15 mutations was higher in patients who had not
been appendectomized.
DISCUSSION
Previous studies have found that around 70-80% of
CD patients require CD-related surgery at least once dur-
ing their lives –often more than once (14). Although pre-
dictive factors for the need of CD-related surgery are not
entirely understood, patients with an ileal location and
stricturing pattern need surgery more frequently. In the
population we analyzed in this study, 51.5% of patients
needed CD-related surgery at least once, although this
frequency is lower than that previously described. This is
probably due to the fact that our cohort is relatively
young, with a mean 7.5 years of follow-up, and with an
important number of patients with less than 4 years of
disease.
The number of patients carrying at least one of the
three CARD15 mutations in the Galician population
(27.9%), although lower than in most European popula-
tions (5,11,12,15-17), permits to evaluate the relationship
between these mutations and CD-related surgery. 
First of all, appendectomy is not significantly associat-
ed with CARD15 mutations. However, it is noteworthy
that in all cases a higher frequency of mutations in pa-
tients who have not experimented appendectomy is ob-
served. It is known that appendectomy has a protective
role against the development of UC. Results are still con-
troversial in CD but it seems that patients needing appen-
dectomy at onset of disease show a more severe course
than patients who had previously experienced appendec-
tomy. This suggests a protective role for the disease. It
has been previously observed that appendectomy may
delay the onset of CD (18,19). Therefore, the results ob-
served in this study may result from a preventive role of
appendectomy in patients with susceptibility genes other
than CARD 15 regarding disease development. 
Regarding CD-related surgery, it appears that
CARD15 gene mutations play a role. The number of cas-
es needing surgical resection is significantly higher for
individuals carrying at least one of the three mutations
previously described as involved in CD. When each mu-
tation is individually studied, it is observed that G908R
and 1007fs are also more frequent in individuals that
have already required surgery. Similar results relate to the
specific study of each surgical indication: ileal resection
and treatment of fistulae. In both cases, patients carrying
one of these mutations show a higher risk of surgical in-
tervention. The fact that the R702W mutation is not relat-
ed to need of surgery confirms the previous observation
that this mutation is not a susceptibility marker for CD in
the Galician population (13).
Regarding the higher need for ileal resection in carri-
ers of CARD15 mutations, this had not been previously
reported, but is consistent with previous reports of a high-
er number of mutations in individuals with fibrostenosis,
normally with ileal location, who are the ones who usual-
ly require surgical resection (11,12,20).
Need for surgery may be considered a signal of severi-
ty, and in this respect our results support the observations
that the CARD15 gene plays a role in susceptibility and
in the severity of disease as previously reported (21-25).
However, it must be noted that despite a relationship
between these mutations and the need for CD-related
surgery, the percentage of patients carrying these muta-
tions that have also required a surgical intervention is still
too low to allow its use in the prediction of disease out-
come in this respect. For the time being we suggest that
patients with CARD15 mutations have more commonly a
severe form of CD requiring surgery. However, studies
with larger numbers of patients are indicated to confirm
this findings.
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Table I. Frequencies (%) for carriers of CARD15 variants in
relation to each surgery studied
R702W G908R 1007fs
Yes 15.7 13.7 17.6
Ileal surgery p = 0.55 p = 0.06 p = 0.01
No 12.3 5.3 4.4
Yes 5.3 31.6 0
Fístula surgery p = 0.27 p = 0.001 p = 0.16
No 14.4 4.8 9.6
Yes 12.5 0 6.3
Appendectomy p = 0.88 p = 0.07 p = 0.61
No 13.5 9.8 9.0
Frequencies are expressed as percentages.
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